Related Experiment Video
Updated: Aug 9, 2026
12:31
A Step by Step Protocol for Subretinal Surgery in Rabbits
Published on: September 13, 2016
Retinal function in rabbits does not improve 4-5 months after terminating treatment with vigabatrin
Ulrika Kjellström1, Sten Kjellström, Anitha Bruun
1Dept. of Ophthalmology, University of Lund, Lund, S 221 85, Sweden. ulrika.kjellstrom@skane.se
Documenta Ophthalmologica. Advances in Ophthalmology
|April 25, 2006
Summary
Vigabatrin treatment in rabbits caused reduced retinal function, specifically the cone b-wave amplitude, which persisted even after medication cessation. However, retinal cell structure appeared normal post-treatment, suggesting vigabatrin
Area of Science:
- Ophthalmology
- Neuroscience
- Pharmacology
Background:
- Previous studies reported retinal changes in rabbits treated with vigabatrin.
- Vigabatrin is an anti-epileptic drug known to affect GABAergic neurotransmission.
Purpose of the Study:
- To evaluate long-term retinal function and histopathology in rabbits after discontinuing vigabatrin treatment.
- To determine if vigabatrin-induced retinal dysfunction is reversible.
Main Methods:
- Rabbits received oral vigabatrin for 12-13 months, followed by a 4-5 month observation period.
- Full-field electroretinograms (ERG) were recorded regularly to assess retinal function.
- Retinal tissue was examined histologically using specific antibodies (GABA, GFAP, GAD, vimentin).
Main Results:
- Vigabatrin treatment significantly reduced dark-adapted cone b-wave amplitude in electroretinograms (p=0.043).
- This ERG reduction persisted 4-5 months after vigabatrin cessation.
- Immunohistology showed no significant differences in retinal morphology or immunoreactivity between treated and control rabbits post-treatment.
Conclusions:
- Vigabatrin-induced retinal dysfunction, indicated by reduced cone b-wave amplitude, may be irreversible.
- Despite persistent functional deficits, retinal morphology and glial cell activity appear reversible after vigabatrin withdrawal.
